Apelin-36 vs Elabela — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-36 is the full-length 36-amino acid form of the apelin peptide family, encoded by the APLN gene. It activates the APJ (APLNR) receptor, a Gi-coupled GPCR, producing cardiovascular effects including vasodilation, positive inotropy, and cardioprotection. The largest naturall...
Calculate Apelin-36 dose →Elabela (also called Apela or Toddler) is the second endogenous peptide ligand for the APJ receptor, discovered in 2013 independently through two approaches: as an essential zebrafish cardiac development factor (Toddler) and as a novel human APJ ligand (Elabela). Unlike apelin pe...
Calculate Elabela dose →| Parameter | Apelin-36 | Elabela |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical / Phase 2 | Research |
| Half-Life | 2-5 minutes (IV) | Short (minutes, estimated) |
| Typical Dose | 1-10 nmol/kg IV (research) | 5-500 nmol/kg (animal) |
| Frequency | Variable | Variable |
| Route | IV / SC (research) | Subcutaneous, Intravenous |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.